Randomized Open Label Study of Standard of Care Plus an Angiotensin II Receptor Blocker Compared to Standard of Care Alone to Minimize the Progression to Respiratory Failure in SARS-CoV-2 Infection
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007382/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this research is to identify whether or not Angiotensin Receptor Blockers
(ARB) can halt the progression to respiratory failure requiring transfer into the intensive
care unit (ICU), as well as halt mechanical ventilation in subjects with mild to moderate
hypoxia due to the corona virus that causes COVID-19. Based on previous animal studies, the
researchers hypothesize that the addition of an ARB is beneficial in abating acute lung
injury in subjects in early stages of SARS-CoV-2 viral induced hypoxia.
提供机构：
Vivli
创建时间：
2021-09-02
